May 13, 2022
Welcoming Ashwin Somasundaram
We’re proud to announce Ashwin Somasundaram, MD, as the newest member of the UNC Lineberger Pancreatic Cancer Center of Excellence (PCCE).
Tag: Clinical Research Program
April 26, 2022
Nanotechnology offers lower cost, high accuracy approach to diagnosing leukemias in low resource countries
A newer, less expensive nanotechnology may make it possible to more accurately diagnose children with acute leukemia in lower income countries, according to findings by Thomas Alexander, MD, MPH, and colleagues.
April 8, 2022
AACR annual meeting to feature UNC Lineberger research
UNC Lineberger researchers and trainees will present nearly 20 research talks and presentations at the 2022 American Association for Cancer Research, April 8-13, in New Orleans.
March 15, 2022
A patient’s decision adds immeasurably to knowledge about how to treat lung cancer
Chad Pecot, MD, and colleagues used biospecimens from a patient just after he succumbed to lung cancer to unravel how a KRAS mutation developed resistance to a treatment that had initially proved effective.
February 10, 2022
Dayton named chair of the Joint UNC-NCSU Department of Biomedical Engineering
Paul Dayton, PhD, the William R. Kenan Distinguished Professor of Biomedical Engineering, has been named chair of the Joint UNC-NCSU Department of Biomedical Engineering.
January 26, 2022
Urologic oncologist makes his mark through robotic surgery program
Marc Bjurlin, DO, MSc, FACOS, specializes in minimally invasive techniques in cancer surgery and brings his expertise to the single port robotic surgery program.
September 10, 2021
Immunotherapy after high-dose chemotherapy leads to favorable outcomes in acute myeloid leukemia
Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.
August 30, 2021
Chemotherapy plus immunotherapy before surgery is beneficial for invasive bladder cancer outcomes
Tracy Rose, MD, MPH, Matthew Milowsky, MD, and colleagues report that the regimen reduced the invasiveness of the cancer in 56% of patients in a phase II clinical trial.
August 16, 2021
Experimental drug that boosts immunotherapy shows promise in bladder cancer study
William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.
November 17, 2020
Immunotherapy for lung and other cancers may also be beneficial for rare skin cancer
Immunotherapies effective against lung cancer and melanoma may also work against cutaneous angiosarcoma, a rare and highly aggressive skin tumor.